Referral success among HIV-infected women and HIV-exposed children referred for monitoring and treatment in Tanga, Tanzania

International Health

Volumn 2, Issue 1, 2010, Pages 36-41

  Arreskov, Anne ^a   Minja, Edith ^b   Theilgaard, Zahra ^a   Mandara, Celine ^c   Gerstoft, Jan ^a   Lemnge, Martha ^c   Katzenstein, Terese L ^a  

^a Rigshospitalet   (Denmark)

^b Bombo Regional Hospital   (Tanzania)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

Antiretroviral therapy; Follow up; HIV; Retention; Sub Saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD HEALTH CARE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MATERNAL CARE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT REFERRAL; PREGNANT WOMAN; PRIORITY JOURNAL; SOCIOECONOMICS; TANZANIA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 77949294524     PISSN: 18763413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inhe.2009.12.010     Document Type: Article

References (21)

1. UNAIDS. HIV prevalence in Tanzania. http://www.unaids.org/en/CountryResponses/Countries/united_republic_of_t anzania.asp (accessed 10 June 2009).
2. Wagner G., Ryan G., and Taylor S. Formative evaluation of antiretroviral therapy scale-up efficiency in sub-Saharan Africa. AIDS Patient Care STDS 21 (2007) 871-888
3. ClinicalTrials.gov. ComTru study. http://clinicaltrials.gov/ct2/show/NCT00346567?cntry1=AF%3ATZ&rank=3 8 (accessed 10 June 2009).
4. UNAIDS. Tanzania National Guidelines, 2007. http://www.unaids.org/en/CountryResponses/Countries/united_republic_of_t anzania.asp (accessed 10 June 2009).
5. WHO/UNAIDS/UNICEF. Joint WHO/UNAIDS/UNICEF statement on use of cotrimoxazole as prophylaxis in HIV exposed and HIV infected children. http://www.who.int/3by5/mediacentre/en/Cotrimstatement.pdf (accessed 10 June 2009).
6. Wikipedia contributors. Tanga, Tanzania. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/wiki/Tanga,_Tanzania (accessed 10 June 2009).
7. Rosen S., Fox M.P., and Gill C.J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4 (2007) e298
8. Wang B, Losina E, Stark R, Munro A, Walensky R, Wilke M, et al. Loss to follow-up in community clinics in South Africa: role of CD4 count, gender and pregnancy. 15th Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008; Boston, MA. CROI 2008; Abstract # 841. http://retroconference.org/2008/Abstracts/32062.htm (accessed 10 June 2009).
9. Yu J.K., Chen S.C., Wang K.Y., Chang C.S., Makombe S.D., Schouten E.J., et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 85 (2007) 550-554
10. Karcher H., Omondi A., Odera J., Kunz A., and Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 12 (2007) 687-694
11. Cantrell R.A., Sinkala M., Megazinni K., Lawson-Marriott S., Washington S., Chi B.H., et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr 49 (2008) 190-195
12. Zachariah R., Teck R., Buhendwa L., Fitzerland M., Labana S., Chinji C., et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg 101 (2007) 79-84
13. Violari A., Cotton M.F., Gibb D.M., Babiker A.G., Steyn J., Madhi S.A., et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359 (2008) 2233-2244
14. Manzi M., Zachariah R., Teck R., Buhendwa L., Kazima J., Bakali E., et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 10 (2005) 1242-1250
15. Sherman G.G., Jones S.A., Coovadia A.H., Urban M.F., and Bolton K.D. PMTCT from research to reality-results from a routine service. S Afr Med J 94 (2004) 289-292
16. Zachariah R., Harries A.D., Luo C., Bachman G., and Graham S.M. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis 7 (2007) 686-693
17. Brinkhof M.W., Dabis F., Myer L., Bangsberg D.R., Boulle A., Nash D., et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86 (2008) 559-567
18. Mshana G.H., Wamoyi J., Busza J., Zaba B., Changalucha J., Kaluvya S., et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 20 (2006) 649-657
19. Brou H., Djohan G., Becquet R., Allou G., Ekouevi D.K., Viho I., et al. When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme. Abidjan. PLoS Med 4 (2007) e342
20. Dahab M., Charalambous S., Hamilton R., Fielding K., Kielmann K., Churchyard G.J., et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health 8 (2008) 63
21. Theilgaard Z, Arreskov A, Chiduo M, Bakari V, Gerstoft J, Bygbjerg I, Katzenstein T. Referral-a crucial sted towards uptake of HAART. Overcoming the crisis of TB and AIDS. Keystone Symposia, Global Health series; 20-25 October 2009; Arusha, Tanzania. Abstract 332.